Articles from this Category
By MICHAEL MILLENSON If you’re used to health tech meetings filled with go-go entrepreneurs and the investors who love them, a conference of academic technology experts can be jarring. Speakers repeatedly pointedContinue reading…
The post Concrete Problems: Experts Caution on Construction of Digital Health Superhighway appeared first on The Health Care Blog.
By MICHAEL MILLENSON Can combining health tech “rah-rah,” health policy “blah-blah” and the “meh” of academic research accelerate the uptake of digital health innovation? AcademyHealth, the health services research policy group, isContinue reading…
By MICHAEL MILLENSON I could’ve been Kamala Harris, Joe Biden and Marianne Williamson all rolled into one. That’s how I might have handled my first, only, and not-so-great presidential debate. No, IContinue reading…
By MICHAEL L. MILLENSON Say you want to know which baseball players provide the most value for the big dollars they’re being paid. A Google search quickly yields analytics. But suppose your primary care physician just diagnosed you with cancer. What will a search for a “high value” cancer doctor tell you? Not much. Public concern over
By MICHAEL L. MILLENSON Say you want to know which baseball players provide the most value for the big dollars they’re being paid. A Google search quickly yields analytics. But suppose your primaryContinue reading…
By MICHAEL L. MILLENSON Say you want to know which baseball players provide the most value for the big dollars they’re being paid. A Google search quickly yields analytics. But suppose your primaryContinue reading…
By MICHAEL MILLENSON Abbott Ventures chief Evan Norton may have spent part of his youth on a farm, but there’s no manure in his manner when speaking of the medical device and diagnostics market landscape. The key, he says, is to avoid being blindsided by the transformational power of digital data. “We’ve been competing against Medtronic and J&J,
By MICHAEL MILLENSON Abbott Ventures chief Evan Norton may have spent part of his youth on a farm, but there’s no manure in his manner when speaking of the medical device and diagnostics market landscape.Continue reading…
By MICHAEL MILLENSON Abbott Ventures chief Evan Norton may have spent part of his youth on a farm, but there’s no manure in his manner when speaking of the medical device and diagnostics market landscape.Continue reading…
By MICHAEL L. MILLENSON A Trump administration regulation issued just hours before the partial federal shutdown offers quiet hope for civility in government. What happened, on its face, was simple: an update of the rules governing a particular Medicare program. In today’s dyspeptic political climate, however, what didn’t happen along the way was truly remarkable – and may